Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Eugen Campian

Obstetrics & Gynecology Red Wing, MN Medical Doctor

NPI 1740319003 CMS profile 260343

701 Hewitt Blvd, Red Wing, MN 55066

Open in the dashboard

General payments

$137,491

179 records reported · program years 2019–2024

Research payments

$2,100

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Eugen Campian of Red Wing, MN is reported in the CMS Open Payments database as having received $137,491 across 179 general payments and $2,100 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $323 5
2023 General $329 3
2023 Research $2,100 1
2022 General $212 4
2021 General $24,578 29
2020 General $40,271 50
2019 General $71,778 88

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eugen Campian
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Eugen Campian were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Eugen Campian Obstetrics & Gynecology median Middle half National median
2019 $71,778 $172 $62–$391 $163
2020 $40,271 $94 $36–$222 $114
2021 $24,578 $136 $42–$369 $132
2022 $212 $160 $50–$433 $149
2023 $329 $169 $56–$423 $160
2024 $323 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. AbbVie, Inc. $128,811 132 payments
  2. Teleflex LLC $3,307 2 payments
  3. Duchesnay USA Incorporated $1,774 3 payments
  4. Coloplast Corp $1,166 9 payments
  5. Axonics Modulation Technologies, Inc. $641 7 payments
  6. Boston Scientific Corporation $445 5 payments
  7. KARL STORZ Endoscopy-America $352 4 payments
  8. CONMED Corporation $300 1 payment
  9. Allergan Inc. $207 2 payments
  10. Checkpoint Surgical, Inc $146 2 payments
  11. Other $342 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $120,925 45 payments
  2. Travel and Lodging $5,266 32 payments
  3. Food and Beverage $5,050 97 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 1 payment
  5. Consulting Fee $2,993 2 payments
  6. Education $57 2 payments
Products named General payments · program years 2019–2024
  1. Orilissa Endocrinology $65,422 67 payments
  2. ORILISSA Womens Health $35,648 42 payments
  3. ORIAHNN $30,509 28 payments
  4. Percutaneous Solutions: PERCUVANCE & MiniLap brands $3,307 2 payments
  5. Osphena $1,774 3 payments
  6. ALTIS $869 7 payments
  7. Advantage System $353 4 payments
  8. Axonics $342 4 payments
  9. Axonics r-SNM System $299 3 payments
  10. TITAN $297 2 payments
  11. Other $1,297 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. AbbVie, Inc. $2,100 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

203

Median for Obstetrics & Gynecology: 65

Drug cost

$7,411

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

21.2%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 48 $3,090
Trospium Chloride Generic 50 $1,983
Estradiol (Once Weekly) Estradiol Brand 14 $674
Methenamine Hippurate Generic 19 $650
Solifenacin Succinate Generic 19 $591
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 29 $313
Oxycodone Hcl Generic 24 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$20,900

Medicare's payments for the services billed

Medicare patients

72

Average age 74

Services billed

305

72 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 54%
Arthritis 50%
Diabetes 25%
Osteoporosis 21%
Depression 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record